News

Clinical trials of the Covid-19 vaccine being developed by Oxford University and AstraZeneca PLC will continue in Brazil despite the death a volunteer, Brazilian health regulator Anvisa said. Oxford University said it had carried out a careful assessment of the...

GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in Phase I/II clinical studies. The data were presented virtually at the ID Week Congress. RSV is...

AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a...

Roche announced that the US FDA has granted full approval of Venclexta® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly diagnosed acute myeloid leukaemia (AML) in adults 75 years or older,...

Vetter, a globally leading contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new building, known as Ravensburg Vetter Kammerbruehl, represents a clear signal from the family-owned company: stability...

MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have  announced that Aurinia Pharmaceuticals Inc. (Aurinia) has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the...

CPhI Worldwide (31 August – 2 September 2021) will be held next year in Milan (Fiera Milano) for the first time in over a decade – following its postponement in 2020. The event returns at an apt moment, as...